(+)-pilocarpine decreases expression ISO RGD:737443 6480464 Pilocarpine results in decreased expression of GAP43 protein CTD PMID:15191797 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GAP43 mRNA CTD PMID:16134595 (S)-amphetamine decreases expression EXP 6480464 Dextroamphetamine results in decreased expression of GAP43 mRNA CTD PMID:11377751 (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of GAP43 mRNA CTD PMID:11377751 (S)-nicotine multiple interactions ISO RGD:737443 6480464 [Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:737443 6480464 [Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:737443 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 17alpha-ethynylestradiol increases expression ISO RGD:737443 6480464 Ethinyl Estradiol results in increased expression of GAP43 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GAP43 mRNA CTD PMID:15834898 more ... 17alpha-ethynylestradiol multiple interactions ISO RGD:737443 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:730980 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA CTD PMID:17404688 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [2 more ... CTD PMID:21436126 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:21436126 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737443 6480464 Tetrachlorodibenzodioxin results in increased expression of GAP43 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GAP43 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737443 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA CTD PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:730980 6480464 2 more ... CTD PMID:26705709 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:737443 6480464 2 more ... CTD PMID:16451863 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects expression ISO RGD:730980 6480464 Verapamil affects the expression of GAP43 protein CTD PMID:12388792 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of GAP43 mRNA, Triiodothyronine results in increased expression of GAP43 protein CTD PMID:15708448 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [sodium arsenite results in decreased expression of GAP43] CTD PMID:25639566 4,4'-sulfonyldiphenol decreases expression ISO RGD:737443 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GAP43 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GAP43 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:730980 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GAP43 mRNA CTD PMID:20147733 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GAP43 mRNA CTD PMID:15749267 , PMID:28959563 acrylamide decreases expression ISO RGD:730980 6480464 Acrylamide results in decreased expression of GAP43 mRNA CTD PMID:32763439 all-trans-retinoic acid increases expression ISO RGD:730980 6480464 Tretinoin results in increased expression of GAP43 mRNA, Tretinoin results in increased expression of GAP43 protein CTD PMID:11027660 more ... all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of GAP43 mRNA, Tretinoin results in increased expression of GAP43 protein CTD PMID:15708448 , PMID:17130476 alpha-D-galactose decreases expression ISO RGD:737443 6480464 Galactose results in decreased expression of GAP43 mRNA CTD PMID:16707173 alpha-D-galactose multiple interactions ISO RGD:737443 6480464 Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] CTD PMID:16707173 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GAP43 mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:730980 6480464 Antimycin A results in decreased expression of GAP43 mRNA CTD PMID:33512557 arachidonic acid increases phosphorylation ISO RGD:737443 6480464 Arachidonic Acid results in increased phosphorylation of GAP43 protein CTD PMID:9852580 arsane decreases expression ISO RGD:737443 6480464 Arsenic results in decreased expression of GAP43 mRNA CTD PMID:19654921 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of GAP43 mRNA CTD PMID:23600209 arsenic atom decreases expression ISO RGD:737443 6480464 Arsenic results in decreased expression of GAP43 mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of GAP43 mRNA CTD PMID:23600209 arsenous acid decreases expression ISO RGD:730980 6480464 Arsenic Trioxide results in decreased expression of GAP43 mRNA CTD PMID:26705709 atrazine increases expression ISO RGD:730980 6480464 Atrazine results in increased expression of GAP43 mRNA CTD PMID:22378314 azamethiphos multiple interactions EXP 6480464 azamethiphos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 azoxystrobin decreases expression ISO RGD:730980 6480464 azoxystrobin results in decreased expression of GAP43 mRNA CTD PMID:33512557 belinostat increases expression ISO RGD:730980 6480464 belinostat results in increased expression of GAP43 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO RGD:737443 6480464 Benzo(a)pyrene results in decreased expression of GAP43 mRNA CTD PMID:27195522 benzo[a]pyrene increases methylation ISO RGD:730980 6480464 Benzo(a)pyrene results in increased methylation of GAP43 exon CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:730980 6480464 Benzo(a)pyrene results in decreased methylation of GAP43 promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:737443 6480464 benzo(b)fluoranthene results in increased expression of GAP43 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:730980 6480464 benzo(e)pyrene results in increased methylation of GAP43 exon CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GAP43 mRNA CTD PMID:25181051 , PMID:31129395 bisphenol A decreases expression ISO RGD:737443 6480464 bisphenol A results in decreased expression of GAP43 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GAP43 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GAP43 gene CTD PMID:28505145 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of GAP43 protein CTD PMID:28903499 butan-1-ol multiple interactions EXP 6480464 1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] CTD PMID:18004999 cadmium atom decreases expression ISO RGD:730980 6480464 Cadmium results in decreased expression of GAP43 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO RGD:737443 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GAP43 mRNA CTD PMID:36114956 cadmium dichloride multiple interactions ISO RGD:737443 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GAP43 mRNA CTD PMID:36114956 calcitriol increases expression ISO RGD:730980 6480464 Calcitriol results in increased expression of GAP43 mRNA CTD PMID:16002434 cannabidiol multiple interactions ISO RGD:730980 6480464 [Cannabidiol co-treated with moringin] results in increased expression of GAP43 protein CTD PMID:30096889 carbamazepine affects expression ISO RGD:737443 6480464 Carbamazepine affects the expression of GAP43 mRNA CTD PMID:22634333 carbon nanotube decreases expression ISO RGD:737443 6480464 Nanotubes, Carbon analog results in decreased expression of GAP43 mRNA CTD PMID:25554681 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of GAP43 mRNA CTD PMID:19395590 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of GAP43 mRNA, carvedilol results in decreased expression of GAP43 protein CTD PMID:20359859 CGP 52608 multiple interactions ISO RGD:730980 6480464 CGP 52608 promotes the reaction [RORA protein binds to GAP43 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:737443 6480464 Chlordecone results in increased expression of GAP43 mRNA CTD PMID:33711761 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GAP43 mRNA CTD PMID:17452286 chlorpyrifos multiple interactions EXP 6480464 Chlorpyrifos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 clobetasol decreases expression ISO RGD:737443 6480464 Clobetasol results in decreased expression of GAP43 mRNA CTD PMID:27462272 clorgyline decreases expression EXP 6480464 Clorgyline results in decreased expression of GAP43 protein CTD PMID:12480131 cobalt dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] more ... CTD PMID:18375950 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of GAP43 mRNA CTD PMID:18375950 cobalt dichloride increases phosphorylation EXP 6480464 cobaltous chloride results in increased phosphorylation of GAP43 protein CTD PMID:18375950 cocaine decreases expression ISO RGD:730980 6480464 Cocaine results in decreased expression of GAP43 mRNA CTD PMID:12629581 crocidolite asbestos decreases expression ISO RGD:737443 6480464 Asbestos, Crocidolite results in decreased expression of GAP43 mRNA CTD PMID:29279043 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of GAP43 protein CTD PMID:10536274 , PMID:9486479 cyfluthrin increases expression ISO RGD:730980 6480464 cyfluthrin results in increased expression of GAP43 mRNA CTD PMID:32028016 cyhalothrin multiple interactions EXP 6480464 cyhalothrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 cypermethrin increases expression ISO RGD:730980 6480464 cypermethrin results in increased expression of GAP43 mRNA CTD PMID:32028016 cytarabine increases expression ISO RGD:730980 6480464 Cytarabine results in increased expression of GAP43 mRNA CTD PMID:21198554 decabromodiphenyl ether affects expression ISO RGD:737443 6480464 decabromobiphenyl ether affects the expression of GAP43 protein CTD PMID:18061678 decabromodiphenyl ether increases expression ISO RGD:737443 6480464 decabromobiphenyl ether results in increased expression of GAP43 protein CTD PMID:25194327 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of GAP43 protein CTD PMID:18753049 deguelin decreases expression ISO RGD:730980 6480464 deguelin results in decreased expression of GAP43 mRNA CTD PMID:33512557 diarsenic trioxide decreases expression ISO RGD:730980 6480464 Arsenic Trioxide results in decreased expression of GAP43 mRNA CTD PMID:26705709 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GAP43 mRNA CTD PMID:17452286 dibenz[a,h]anthracene increases expression ISO RGD:737443 6480464 1 more ... CTD PMID:26377693 dieldrin multiple interactions EXP 6480464 Dieldrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 dioxygen multiple interactions EXP 6480464 [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of GAP43 protein CTD PMID:27693381 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GAP43 mRNA CTD PMID:25152437 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] CTD PMID:8774942 dorsomorphin multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:730980 6480464 Doxorubicin results in increased expression of GAP43 mRNA CTD PMID:30031762 doxycycline increases expression EXP 6480464 Doxycycline results in increased expression of GAP43 protein CTD PMID:33798505 entinostat multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:730980 6480464 entinostat results in increased expression of GAP43 mRNA CTD PMID:26272509 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of GAP43 mRNA CTD PMID:15940294 ethanol multiple interactions ISO RGD:737443 6480464 Ethanol affects the expression of and affects the splicing of GAP43 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] CTD PMID:15940294 fasudil multiple interactions EXP 6480464 [fasudil co-treated with Methylmercury Compounds] results in increased expression of and results in increased phosphorylation of GAP43 protein CTD PMID:30462329 fenpyroximate decreases expression ISO RGD:730980 6480464 fenpyroximate results in decreased expression of GAP43 mRNA CTD PMID:33512557 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of GAP43 mRNA CTD PMID:30307764 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of GAP43 mRNA CTD PMID:17950272 flusilazole affects expression ISO RGD:737443 6480464 flusilazole affects the expression of GAP43 mRNA CTD PMID:22634333 folic acid decreases expression ISO RGD:737443 6480464 Folic Acid results in decreased expression of GAP43 mRNA CTD PMID:25629700 galactose multiple interactions ISO RGD:737443 6480464 Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] CTD PMID:16707173 galactose decreases expression ISO RGD:737443 6480464 Galactose results in decreased expression of GAP43 mRNA CTD PMID:16707173 glyphosate decreases expression ISO RGD:730980 6480464 glyphosate results in decreased expression of GAP43 mRNA CTD PMID:31874349 Goe 6976 multiple interactions ISO RGD:730980 6480464 Go 6976 inhibits the reaction [isophthalate analog results in increased expression of GAP43 protein] CTD PMID:23643828 heptachlor multiple interactions EXP 6480464 Heptachlor promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] CTD PMID:28385489 imipramine decreases expression EXP 6480464 Imipramine results in decreased expression of GAP43 mRNA CTD PMID:17950272 isophthalic acid multiple interactions ISO RGD:730980 6480464 Go 6976 inhibits the reaction [isophthalate analog results in increased expression of GAP43 protein] CTD PMID:23643828 isophthalic acid increases expression ISO RGD:730980 6480464 isophthalate analog results in increased expression of GAP43 mRNA, isophthalate analog results in increased expression of GAP43 protein CTD PMID:23643828 kainic acid multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA], Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] CTD PMID:8774942 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of GAP43 mRNA CTD PMID:8774942 lead diacetate multiple interactions ISO RGD:730980 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein] more ... CTD PMID:31843630 lead(0) multiple interactions ISO RGD:730980 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein] more ... CTD PMID:31843630 lead(2+) multiple interactions ISO RGD:730980 6480464 [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein] more ... CTD PMID:31843630 lipopolysaccharide decreases expression ISO RGD:737443 6480464 Lipopolysaccharides results in decreased expression of GAP43 mRNA CTD PMID:12057914 lovastatin increases expression ISO RGD:737443 6480464 Lovastatin results in increased expression of GAP43 protein CTD PMID:20694854 lovastatin increases expression ISO RGD:730980 6480464 Lovastatin results in increased expression of GAP43 protein CTD PMID:20694854 Meclizine affects expression ISO RGD:730980 6480464 Meclizine affects the expression of GAP43 protein CTD PMID:12388792 megestrol affects expression ISO RGD:730980 6480464 Megestrol affects the expression of GAP43 protein CTD PMID:12388792 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Methamphetamine results in decreased expression of GAP43 protein] CTD PMID:19409439 melittin increases phosphorylation ISO RGD:737443 6480464 Melitten results in increased phosphorylation of GAP43 protein CTD PMID:9852580 menadione increases expression ISO RGD:730980 6480464 Vitamin K 3 analog results in increased expression of GAP43 mRNA CTD PMID:19273458 methamphetamine multiple interactions EXP 6480464 Melatonin inhibits the reaction [Methamphetamine results in decreased expression of GAP43 protein] CTD PMID:19409439 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of GAP43 protein CTD PMID:19409439 methapyrilene increases methylation ISO RGD:730980 6480464 Methapyrilene results in increased methylation of GAP43 exon CTD PMID:30157460 Methazolamide affects expression ISO RGD:730980 6480464 Methazolamide affects the expression of GAP43 protein CTD PMID:12388792 Mipafox decreases expression ISO RGD:730980 6480464 mipafox results in decreased expression of GAP43 protein CTD PMID:27939611 N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide affects expression ISO RGD:730980 6480464 Methazolamide affects the expression of GAP43 protein CTD PMID:12388792 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] CTD PMID:18375950 nickel atom affects expression EXP 6480464 Nickel affects the expression of GAP43 mRNA CTD PMID:18812211 nicotine multiple interactions ISO RGD:737443 6480464 [Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23933227 Oxadiazon multiple interactions ISO RGD:730980 6480464 ACYP2 protein affects the reaction [oxadiazon inhibits the reaction [BDNF protein results in increased expression of GAP43 protein]] more ... CTD PMID:30391265 ozone multiple interactions ISO RGD:737443 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GAP43 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:730980 6480464 panobinostat results in increased expression of GAP43 mRNA CTD PMID:26272509 paraoxon decreases expression ISO RGD:730980 6480464 Paraoxon results in decreased expression of GAP43 protein CTD PMID:27939611 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GAP43 mRNA CTD PMID:18198484 pentobarbital multiple interactions EXP 6480464 Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] CTD PMID:8774942 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [2 more ... CTD PMID:21436126 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of GAP43 protein CTD PMID:25524167 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GAP43 mRNA, perfluorooctane sulfonic acid results in increased expression of GAP43 protein CTD PMID:21436126 , PMID:25524167 perfluorooctane-1-sulfonic acid increases expression ISO RGD:737443 6480464 perfluorooctane sulfonic acid results in increased expression of GAP43 protein CTD PMID:19211617 perfluorooctanoic acid increases expression ISO RGD:737443 6480464 perfluorooctanoic acid results in increased expression of GAP43 protein CTD PMID:19211617 phencyclidine increases expression EXP 6480464 Phencyclidine results in increased expression of GAP43 mRNA CTD PMID:11377751 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GAP43 mRNA CTD PMID:15059925 picoxystrobin decreases expression ISO RGD:730980 6480464 picoxystrobin results in decreased expression of GAP43 mRNA CTD PMID:33512557 potassium chloride multiple interactions EXP 6480464 1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] more ... CTD PMID:18004999 potassium chloride increases expression EXP 6480464 Potassium Chloride results in increased expression of GAP43 mRNA, Potassium Chloride results in increased expression of GAP43 protein CTD PMID:18004999 progesterone multiple interactions ISO RGD:730980 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA CTD PMID:17404688 progesterone multiple interactions ISO RGD:737443 6480464 Progesterone inhibits the reaction [VPS54 mutant form results in increased expression of GAP43 mRNA] CTD PMID:19693665 pyrimidifen decreases expression ISO RGD:730980 6480464 pyrimidifen results in decreased expression of GAP43 mRNA CTD PMID:33512557 quercetin multiple interactions ISO RGD:737443 6480464 Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] CTD PMID:16707173 resveratrol decreases expression ISO RGD:730980 6480464 resveratrol results in decreased expression of GAP43 mRNA CTD PMID:12002526 rotenone decreases expression ISO RGD:730980 6480464 Rotenone results in decreased expression of GAP43 mRNA CTD PMID:33512557 Salinomycin decreases expression ISO RGD:730980 6480464 salinomycin results in decreased expression of GAP43 mRNA CTD PMID:19682730 sarin decreases expression ISO RGD:730980 6480464 Sarin results in decreased expression of GAP43 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopolamine decreases expression ISO RGD:730980 6480464 Scopolamine results in decreased expression of GAP43 protein CTD PMID:22096544 scopolamine multiple interactions ISO RGD:730980 6480464 Ashwagandha inhibits the reaction [Scopolamine results in decreased expression of GAP43 protein], withanone inhibits the reaction [Scopolamine results in decreased expression of GAP43 protein] CTD PMID:22096544 sodium arsenite increases expression ISO RGD:730980 6480464 sodium arsenite results in increased expression of GAP43 mRNA CTD PMID:12016162 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GAP43 CTD PMID:25639566 sodium arsenite multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [sodium arsenite results in decreased expression of GAP43] CTD PMID:25639566 sulindac affects expression ISO RGD:730980 6480464 Sulindac affects the expression of GAP43 protein CTD PMID:12388792 tebufenpyrad decreases expression ISO RGD:730980 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of GAP43 mRNA CTD PMID:33512557 Testosterone propionate increases expression EXP 6480464 Testosterone Propionate results in increased expression of GAP43 mRNA CTD PMID:19427307 thapsigargin decreases expression ISO RGD:730980 6480464 Thapsigargin results in decreased expression of GAP43 mRNA CTD PMID:22378314 thyroxine increases expression EXP 6480464 Thyroxine results in increased expression of GAP43 mRNA CTD PMID:15940294 thyroxine multiple interactions EXP 6480464 Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] CTD PMID:15940294 titanium dioxide decreases expression ISO RGD:737443 6480464 titanium dioxide results in decreased expression of GAP43 mRNA CTD PMID:19464567 trichlorfon decreases expression ISO RGD:730980 6480464 Trichlorfon results in decreased expression of GAP43 protein CTD PMID:27939611 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of GAP43 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:730980 6480464 trichostatin A results in increased expression of GAP43 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 tris(2-chloroethyl) phosphate decreases expression EXP 6480464 tris(chloroethyl)phosphate results in decreased expression of GAP43 mRNA, tris(chloroethyl)phosphate results in decreased expression of GAP43 protein CTD PMID:24717766 Tryptanthrine increases expression ISO RGD:730980 6480464 tryptanthrine results in increased expression of GAP43 mRNA CTD PMID:23500671 tunicamycin decreases expression ISO RGD:730980 6480464 Tunicamycin results in decreased expression of GAP43 mRNA CTD PMID:22378314 undecane increases expression EXP 6480464 undecane results in increased expression of GAP43 protein CTD PMID:17337753 valproic acid affects expression ISO RGD:730980 6480464 Valproic Acid affects the expression of GAP43 mRNA CTD PMID:25979313 , PMID:26072468 valproic acid multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:730980 6480464 Valproic Acid results in increased expression of GAP43 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:737443 6480464 Valproic Acid affects the expression of GAP43 mRNA CTD PMID:26072468 verapamil affects expression ISO RGD:730980 6480464 Verapamil affects the expression of GAP43 protein CTD PMID:12388792 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of GAP43 gene CTD PMID:31682807 vorinostat multiple interactions ISO RGD:730980 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:730980 6480464 vorinostat results in increased expression of GAP43 mRNA CTD PMID:26272509 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of GAP43 mRNA CTD PMID:17557909 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] CTD PMID:18375950 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] CTD PMID:18375950
